The in vivo anti-glioblastoma effects of Res can be distinctly improved in the form of Pep-PP@Res nanoparticles via activating JNK signaling, upregulating proapoptosis gene expression, finally resulting in extensive apoptosis. Here, MAPK8 is linked to glioblastoma.